Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Sonic Healthcare Limited ( (AU:SHL) ) has issued an update.
Sonic Healthcare Limited reported a strong financial performance for the fiscal year ending June 2025, with a net profit of A$514 million and revenues of approximately A$9.6 billion. The company achieved 5% organic revenue growth and expanded its EBITDA margin by 40 basis points. Key strategic moves included the acquisition of LADR Laboratory Group in Germany and Cairo Diagnostics in the USA, which are expected to drive future growth and enhance market positioning. The company anticipates continued earnings growth in FY2026, driven by organic growth and synergies from recent acquisitions, despite challenges in some markets such as the USA and Belgium.
The most recent analyst rating on (AU:SHL) stock is a Hold with a A$29.00 price target. To see the full list of analyst forecasts on Sonic Healthcare Limited stock, see the AU:SHL Stock Forecast page.
More about Sonic Healthcare Limited
Sonic Healthcare Limited is a global healthcare company based in Sydney, Australia, specializing in medical diagnostics and laboratory services. The company operates in various international markets, providing services such as pathology, radiology, and clinical services, with a significant presence in countries like Germany, Switzerland, the USA, and the UK.
Average Trading Volume: 1,104,757
Technical Sentiment Signal: Buy
Current Market Cap: A$14.09B
Find detailed analytics on SHL stock on TipRanks’ Stock Analysis page.